Health care stocks leaned lower premarket Monday as the Health Care Select Sector SPDR Fund (XLV) was down 0.5% and the iShares Biotechnology ETF (IBB) declined by 1.6% recently.
Owens & Minor (OMI) shares fell past 1% after the company said it expects to record a Q4 non-cash goodwill impairment charge in its Apria division of about $310 million, or around a $4 net loss per share. The company also reported preliminary Q4 revenue that missed market expectations.
Becton Dickinson (BDX) is considering a potential separation of its life sciences division, according to media reports. Becton Dickinson shares were up over 0.5% pre-bell.
GH Research (GHRS) shares rose past 89% after the company said a phase 2b clinical trial of GH001 for patients with treatment-resistant depression met its primary endpoint.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。